StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
BIOEN.IS$16.93-0.70%
Fair $16.93+0.0%

BIOEN.IS

Biotrend Cevre ve Enerji Yatirimlari A.S.

Utilities / Utilities - RenewableIstanbul

$16.93

-0.12 (-0.70%)

Fairly Valued+0.0%Fair Value $16.93Fund rank 21/100 · Data gapFallback financials|
SA 29/D
F-Score: 4/9
Margin CompressionLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $100.5M · quality 27.0/100

Data gap 21/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

29/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Operating margin has declined for 3 consecutive years ROE is -49.6%, below the 5% threshold
Thesis & Journal · BIOEN.ISLocal privado en este navegador · Biotrend Cevre ve Enerji Yatirimlari A.S.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$8.5B

P/E

4.4x

↓

EV/EBITDA

19.8x

↑

ROE

-49.6%

↓

Gross Margin

3.4%

↓

Debt/Equity

1.86

↑
52-Week Range$17
$15$28

TradingView lightweight chart

BIOEN.IS price, volumen y niveles de valoración

Último $16.93Periodo +225.3%
Fair value: $16.93

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+8.0%

FCF CAGR

—

FCF margin

5.2%

FCF / Net income

-0.11x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.94B · net income $-1.38B · FCF $153.7M

2022-FY → 2025-FY

Gross margin

3.4%-30.7% pts

Operating margin

-18.2%-41.8% pts

Net margin

-47.0%-71.6% pts

FCF margin

5.2%+20.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.94B$2.94B$3.56B$3.22B$2.34B
Net Income$-1.38B$-1.38B$-87.6M$1.37B$576.8M
EBITDA$687.5M$687.5M$1.34B$2.42B$1.08B
EPS2.762.760.182.741.15
Gross Margin3.4%3.4%-0.7%15.1%34.1%
Operating Margin-18.2%-18.2%-17.0%1.5%23.6%
Net Margin-47.0%-47.0%-2.5%42.5%24.7%
Balance Sheet
Debt/Equity1.861.861.141.251.15
Current Ratio0.310.31———
Cash Flow
Free Cash Flow$153.7M$153.7M$-2.37B$100.5M$-346.9M
Returns
ROE-49.6%-49.6%-2.0%29.2%23.4%
Valuation
P/E4.444.4493.676.9214.90
EV/EBITDA19.7819.7810.036.2310.48
P/B3.043.041.882.023.48
Growth & Yield
Revenue Growth-17.3%-17.3%10.4%37.9%—
EPS Growth1433.3%1433.3%-93.4%138.3%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-18.4%

fácil

EPS terminal req.

$1.50

Spread vs growth

1451.7%

5Y implied EPS CAGR

-8.0%

fácil

EPS terminal req.

$1.82

Spread vs growth

1441.3%

10Y implied EPS CAGR

0.6%

fácil

EPS terminal req.

$2.93

Spread vs growth

1432.7%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -19.4%

Total return

-19.4%

Start / end P/E

116.7x → 6.1x

EPS bridge

0.18 → 2.76

Residual

-1358.0%

EPS growth+1433.3%
Multiple rerating-94.7%
Dividend+0.0%
Residual / FX / buybacks / cross-term-1358.0%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.